RHUMBLINE ADVISERS - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$207,521
+27.9%
87,197
-5.4%
0.00%
Q2 2023$162,203
+6.0%
92,161
+170.6%
0.00%
Q1 2022$153,000
-27.5%
34,064
+10.1%
0.00%
Q4 2021$211,000
-7.9%
30,927
-1.6%
0.00%
Q3 2021$229,000
-24.9%
31,443
+3.2%
0.00%
Q2 2021$305,000
+43.9%
30,461
+37.5%
0.00%
Q1 2021$212,000
+87.6%
22,160
+114.3%
0.00%
Q4 2020$113,00010,3420.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders